New Delhi [India], February 17 (ANI): A preliminary result of an Israeli study to evaluate the safety of EXO-CD24 exosomes in 30 enrolled patients with COVID-19 disease has claimed to show no serious adverse effects, and substantial improvement in respiratory rate, Professor Nadar Arber from
Washington (US), February 17 (ANI): During recent research, an important early step in developing a new class of therapeutics has been taken by a McMaster stem cell research team for patients with deadly blood cancer.
Nizamabad (Telangana) [India], February 16 (ANI): With a hope to serve thousands on an hourly basis, Telangana Rashtra Samithi (TRS) Member of Legislative Council (MLC) Kavitha Kalvakuntla on Monday inaugurated a free meal centre in Telangana's Nizamabad.
Washington [US], February 16 (ANI): Researchers have developed a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.
Washington [US], February 16 (ANI): A study led by researchers of the Massachusetts Institute of Technology has developed a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients.
Mumbai (Maharashtra) [India], February 15 (ANI/PRNewswire): In an effort to provide preventive and effective healthcare solutions to every patient, Dr Batra's has revolutionized the future of homeopathy through scientific, precise, safe and uniquely planned treatment solutions. Through its l
Chandigarh (Punjab) [India], February 15 (ANI): In view of extending the medical benefits to high-risk groups, the Punjab government established 59 Hepatitis treatment centres in three years in the state under National Viral Hepatitis Control Programme (NVHCP) to treat such patients acros
Singapore, February 15 (ANI): Digital solutions will help in creating a comprehensive and integrated healthcare ecosystem across India and support the patients to get access to high-quality and cost-effective care, according to Fitch Solutions.
Washington [US], February 15 (ANI): Recent research in a SWOG Cancer Research Network trial that put three targeted drugs to the test, found cabozantinib, which is a small molecule inhibitor, most effective in treating patients with metastatic papillary kidney cancer.
Washington [US], February 14 (ANI): Patients, who suffer from type 2 diabetes and experience extreme swings in their blood sugar levels, are at an increased risk of heart disease-- suggest the findings of a new study.
Washington [US], February 14 (ANI): In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practic
Massachusetts [US], February 14 (ANI): A new clinical study published in The New England Journal of Medicine today and simultaneously presented during the American Society of Clinical Oncology (ASCO) 2021 Genitourinary Cancers Symposium claims that a drug combination of Lenvatinib plus pemb